The drive to advance precision medicine at The Jackson Laboratory for Genomic Medicine (JAX) in Farmington, Conn. began in 2014. To continue the momentum, JAX is now seeking to hire over 60 genomic researchers, bioinformaticians, software/IT engineers and administrative staff to join JAX’s world-class faculty and staff in their quest to find precise genomic solutions for disease.
Growth at JAX has been rapid since the research institute opened its permanent facility. “When we opened JAX’s Farmington campus in 2014, I was the second hire and the excitement was — and still is — palpable,” says Site Director Yu-Hui Rogers. “The state of Connecticut’s long-term commitment to bioscience and The Jackson Laboratory’s reputation as a world-class research organization were big draws for me, and, as we’re finding with the incredible pace at which JAX is hiring, we are attractive to top scientists from around the world.”
JAX faculty currently conduct research in the areas of cancer, microbiome neuroscience, immunology, aging/metabolism and reproduction/development. Leveraging JAX’s strengths in mammalian genetics and human genomics will allow JAX to identify complex causes of disease and develop diagnostics and therapeutics to empower the global medical community and Connecticut’s growing bioscience industry. Additionally, JAX has developed predoctoral and postdoctoral training programs to develop the skills necessary for career advancement.
JAX researchers are collaborating with Connecticut’s leading medical institutions — including the University of Connecticut Health Center, Connecticut Children’s Medical Center and the Yale University School of Medicine. JAX team members enjoy a uniquely collaborative environment that fosters interdisciplinary “team science” with no departmental barriers and superior scientific support services to foster innovative research. JAX has also developed collaborations with leading institutions around the country and around the world. Recent work with M.D. Anderson Cancer Center seeks to use JAX’s new cancer profiling assay to pinpoint where in the body cancers arise when their origin is unknown. The data generated will guide therapy decisions based on the genetics of each patient’s tumor cells.
JAX’s hiring mission in 2017 kicks off with a Career Forum on March 28 and will continue throughout the year. Within the next few years, discoveries at JAX will not only advance personalized medicine, but will continue to grow Connecticut’s bioscience industry.
Learn more about opportunities at JAX at www.jax.org/careers.